§ 5903. Xylazine awareness education.

255 words·~1 min read·/pa/title-35/chapter-59/5903

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)Powers and duties.-- The Department of Drug and Alcohol Programs, in consultation with the Department of Health and the Department of Agriculture, shall have the power and its duty shall be to:

(1)Enter into partnerships with health care providers, including physicians and veterinarians, and community-based health centers and hospitals to educate residents of this Commonwealth on the dangers of human use of xylazine.

(2)Create informational materials in electronic and physical form, in coordination with the partners described in paragraph (1), which may be distributed to or accessed by residents of this Commonwealth. The informational materials shall include:

(i)The effects on the human body of the use of xylazine.

(ii)How to talk to family and friends about the dangers of human use of xylazine.

(iii)The legitimate uses of xylazine for animal use.

(iv)Any other information that the Department of Drug and Alcohol Programs deems necessary to prepare and educate residents of this Commonwealth on the dangers of human use of xylazine.

(b)Expiration.-- Upon a determination by the Secretary of Health that the human use of xylazine no longer poses a significant threat to the public health and safety of the Commonwealth, the Secretary of Health shall transmit notice of the determination to the Legislative Reference Bureau for publication in the next available issue of the Pennsylvania Bulletin. This section shall expire upon publication of the notice under this subsection.

35c5903v

Cross References. Section 5903 is referred to in section 5902 of this title.